Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Comment by RichyRich$on Sep 09, 2020 5:23am
127 Views
Post# 31525266

RE:RE:bummer

RE:RE:bummerShaz... I don't think it'll make a new low. The reason... because last May it briefly plunged from $10.00 to $7.50 because it was dropping for all of 2019 without any significant pops. Now that everyone saw the huge 3.6 X Gain pop in 2 weeks last May. The big money gave their hand away. They see value in Aurora. Everyone will be savoring the next 3 to 4 X Gain pop! Retail investors will start piling on too. Everyone remembers last May. This beast is capable of quadrupling in 2 weeks based on last May! When in made the fast plunge last May... it was doom and gloom of dropping for all of 2019 and no technical analysis hope. Now, things are better than last May even. I read a Seeking Aplha article from yesterday. It said that the $1.7 Billion write-down was already known by Wall Street. They already knew about it. Estimated Revenue barely missed the consensus. Yesterday they pretty well threw us a curve ball and gave us the expected numbers for the next quarter report. The report is on September 22. But they pretty well gave the numbers now. So theres no more bad news to drive it down. The new CEO is the COO that started last May. Seeking Alpha also said that they only need $80M revenue to be positive EBITDA cash flow. Right now around $70M Revenue. But they think they can be positive cash flow just by lowering expenses and improving efficiency. So there's no risk here. Even after the write down... it's worth $3 Billion total assets it said. Market Cap only $1 Billion. Over $240M in cash. Remember Aurora and Aphria were gonna merge. Who knows if those talks don't resume again!
<< Previous
Bullboard Posts
Next >>